BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37165775)

  • 1. Characterizing opioid use in a Dutch cohort with migraine.
    van Welie RF; van Welie FC; de Vries Lentsch S; Dahan A; van Velzen M; Terwindt GM
    Cephalalgia; 2023 May; 43(5):3331024231174160. PubMed ID: 37165775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study.
    Lipton RB; Buse DC; Dodick DW; Schwedt TJ; Singh P; Munjal S; Fanning K; Bostic Bs R; Reed ML
    Headache; 2021 Jan; 61(1):103-116. PubMed ID: 33326608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB
    Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world assessment of concomitant opioid utilization and associated trends in patients with migraine.
    Kangethe A; Polson M; Evangelatos TM; Speicher LC; Tenaglia AT; Staats PS; Liebler EJ; Mwamburi M
    Am J Manag Care; 2020 Feb; 26(1 Suppl):S8-S14. PubMed ID: 32109019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of Opioid and Barbiturate Prescriptions in Patients Attending a Tertiary Care Headache Center.
    Minen MT; Lindberg K; Wells RE; Suzuki J; Grudzen C; Balcer L; Loder E
    Headache; 2015 Oct; 55(9):1183-91. PubMed ID: 26316376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of opioids in the treatment of primary headache disorders].
    Totzeck A; Gaul C
    Schmerz; 2014 Apr; 28(2):135-40. PubMed ID: 24500765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing opioid use in a US population with migraine: Results from the CaMEO study.
    Lipton RB; Buse DC; Friedman BW; Feder L; Adams AM; Fanning KM; Reed ML; Schwedt TJ
    Neurology; 2020 Aug; 95(5):e457-e468. PubMed ID: 32527971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the factors underlying discontinuation of triptans.
    Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
    Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic variation in the use of triptans and opioids for the acute treatment of migraine attacks.
    Lee JH; Shewale AR; Barthold D; Devine B
    Headache; 2021 Nov; 61(10):1499-1510. PubMed ID: 34841520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world opioid use among patients with migraine enrolled in US commercial insurance and risk factors associated with migraine progression.
    Shao Q; Rascati KL; Lawson KA; Barner JC; Sonawane KB; Rousseau JF
    J Manag Care Spec Pharm; 2022 Nov; 28(11):1272-1281. PubMed ID: 36282930
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioids can be useful in the treatment of headache.
    Finocchi C; Viani E
    Neurol Sci; 2013 May; 34 Suppl 1():S119-24. PubMed ID: 23695059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment.
    Ansari H; Kouti L
    Curr Pain Headache Rep; 2016 Aug; 20(8):50. PubMed ID: 27457368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids in headache treatment. Is there a role?
    Ziegler DK
    Neurol Clin; 1997 Feb; 15(1):199-207. PubMed ID: 9058406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid use among adolescent patients treated for headache.
    DeVries A; Koch T; Wall E; Getchius T; Chi W; Rosenberg A
    J Adolesc Health; 2014 Jul; 55(1):128-33. PubMed ID: 24581795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids in headache.
    Levin M
    Headache; 2014 Jan; 54(1):12-21. PubMed ID: 24127913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Ezzati A; Buse DC; Fanning KM; Reed ML; Martin VT; Lipton RB
    Clin Neurol Neurosurg; 2022 Dec; 223():107511. PubMed ID: 36395587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of switching acute treatment on disability in migraine patients using triptans.
    Serrano D; Buse DC; Kori SH; Papapetropoulos S; Cunanan CM; Manack AN; Reed ML; Lipton RB
    Headache; 2013 Oct; 53(9):1415-29. PubMed ID: 23808937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.